Improvement in Treatment Results and Long-Term Survival of Patients with Esophageal Cancer: Impact of Chemoradiation and Change in Treatment Strategy

Annals of Surgery

Volumn 238, Issue 3, 2003, Pages 339-348

  Law, Simon ^a   Kwong, Dora L W ^a   Kwok, Ka Fai ^a   Wong, Kam Ho ^a   Chu, Kent Man ^a   Sham, Jonathan S T ^a   Wong, John ^a   Demeester, Tom R ^b   Pellegrini, Carlos A ^b   Krupski, William C ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR LOCALIZATION; ADJUVANT THERAPY; ARTICLE; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FOLLOW UP; LYMPHADENECTOMY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; SURVIVAL RATE; TIME;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 0141871983     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Whooley BP, Law S, Murthy SC, et al. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338-344.
2. Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232:225-232.
3. Watanabe H, Kato H, Tachimori Y. Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan. Recent Results Cancer Res. 2000;155:123-133.
4. Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520-530.
5. Ellis-FH J, Heatley GJ, Krasna MJ, et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg. 1997;113:836-846.
6. Hulscher JB, Tijssen JG, Obertop H, et al. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg. 2001;72:306-313.
7. Law S, Wong J. Esophagogastrectomy for carcinoma of the esophagus and cardia, and the esophageal anastomosis. In: Baker RJ, Fischer JE, eds. Master of Surgery. Philadelphia: Lippincott Williams & Wilkins; 2001:813-827.
8. Law S, Wong J. Esophagectomy without thoracotomy. In: Baker RJ, Fischer JE, eds. Mastery of Surgery. Philadelphia: Lippincott Williams & Wilkins; 2001:828-836.
9. Chu KM, Law SY, Fok M, et al. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg. 1997;174:320-324.
10. Law S, Fok M, Chu KM, et al. Thoracoscopic esophagectomy for esophageal cancer. Surgery. 1997;122:8-14.
11. Law SY, Fok M, Wei WI, et al. Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy. Ann Thorac Surg. 2000;70:418-422.
12. Law SY, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg. 1996;83:107-111.
13. Law S, Wong J. Two-field dissection is enough for esophageal cancer. Dis Esophagus. 2001;14:98-103.
14. Law S, Wong J. Does lymphadenectomy add anything to the treatment of esophageal cancer? Adv Surg. 1999;33:311-327.
15. Law S, Fok M, Chu KM, et al. Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg. 1997;226:169-173.
16. Law S, Fok M, Chow S, et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg. 1997;114:210-217.
17. Iizuka T, Isono K, Kakegawa T, et al. Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese Committee for Registration of Esophageal Carcinoma Cases. Chest. 1989;96:1005-1011.
18. Badwe RA, Patil PK, Bhansali MS, et al. Impact of age and sex on survival after curative resection for carcinoma of the esophagus. Cancer. 1994;74:2425-2429.
19. Tanabe G, Baba M, Kuroshima K, et al. Clinical evaluation of the esophageal lymph flow system based on RI uptake of dissected regional lymph nodes following lymphoscintigraphy. Nippon Geka Gakkai Zasshi. 1986;87:315-323.
20. Vigneswaran WT, Trastek VF, Pairolero PC, et al. Extended esophagectomy in the management of carcinoma of the upper thoracic esophagus. J Thorac Cardiovasc Surg. 1994;107:901-906.
21. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three fields of lymph node dissection in esophageal cancer. Oncology. 1991;48:411-420.
22. Kato H, Tachimori Y, Watanabe H, et al. Thoracic esophageal carcinoma above the carina: a more formidable adversary? J Surg Oncol. 1997;65:28-33.
23. Hosokawa M, Shirato H, Ohara M, et al. Intraoperative radiation therapy to the upper mediastinum and nerve-sparing three-field lymphadenectomy followed by external beam radiotherapy for patients with thoracic esophageal carcinoma. Cancer. 1999;86:6-13.
24. Arimoto T, Takamura A, Tomita M, et al. Intraoperative radiotherapy for esophageal carcinoma-significance of IORT dose for the incidence of fatal tracheal complication. Int J Radiat Oncol Biol Phys. 1993;27:1063-1067.
25. Bollschweiler E, Schroder W, Holscher AH, et al. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg. 2000;87:1106-1110.
26. Doty JR, Salazar JD, Forastiere AA, et al. Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy. Ann Thorac Surg. 2002;74:227-231.
27. Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234:360-367.
28. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg. 1999;230:392-400.
29. Hofstetter W, Swisher SG, Correa AM, et al. Treatment outcomes of resected esophageal cancer. Ann Surg. 2002;236:376-384.
30. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-1669.
31. Hospital Authority Hong Kong. Clinical audit on esophagectomy and hepatectomy in Hong Kong. Hong Kong: Hospital Authority Hong Kong; 2002.
32. Pye JK, Crumplin MK, Charles J, et al. One-year survey of carcinoma of the oesophagus and stomach in Wales. Br J Surg. 2001;88:278-285.
33. Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg. 1998;85:840-844.
34. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337:161-167.
35. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462-467.
36. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305-313.
37. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer. 1994;73:1779-1784.
38. Law S. Chemoradiotherapy-Panacea for esophageal cancer? Commentary for "Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA Southeast Asia. 1999;15:9-11.
39. Law S, Wong J. New adjuvant therapies for esophageal cancer. Adv Surg. 2001;35:271-295.